We confirmed MYCN amplification, a NB hallmark related to poor outcome of the HR patients in patients older than 1 year [12], 1p deletion, 11q loss and 17q gain, that occurs in about 50% of the tumours [13]. Here, MYCN is linked to neoplasm.